Releaf Acquires Domain Releaf.com for £110,000
Releaf Acquires Domain Releaf.com for £110,000 to Support Long Term Growth.The UK's fastest-growing medicinal cannabis clinic begins international strategy with...
Pharmaceutical
Releaf Acquires Domain Releaf.com for £110,000
The UK's fastest-growing medicinal cannabis clinic begins international strategy with further online investment. NOTTINGHAM, ENGLAND / ACCESS Newswire / September...
Florence Announces AI-Assisted Workflows to Transform Clinical Trials
ATLANTA, GA / ACCESS Newswire / September 2, 2025 / Ahead of its premier life science event advancing Clinical Trial...
Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Patent-Pending AI Mental Health Tracker Targeting $400 Billion Market
MESA, ARIZONA / ACCESS Newswire / September 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an innovator in AI-powered...
MicroGenDX’s New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions
Adoption of Illumina's MiSeq i100 Plus accelerates results delivery to next-day from sample receipt, speeding up patient care when time...
CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors
- Industry veteran brings extensive senior level leadership and expertise in biologics development, strategic partnerships, mergers and acquisitions across biotech...
New World Medical Introduces the Ahmed ClearPath(R) ST Glaucoma Drainage Device
The Ahmed ClearPath® ST addresses market demands by expanding the trusted Ahmed ClearPath® brand to now feature a smaller tube...
VSee Health Teleradiology Expands to 25 Hospitals for an Estimated $3.0 Million Annualized Revenue
SAN JOSE, CALIFORNIA / ACCESS Newswire / September 2, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions,...
1933 Industries Announces Repurchase and Cancellation of Convertible Debentures
VANCOUVER, BC / ACCESS Newswire / September 2, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a...
Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
CAMBRIDGE, MA / ACCESS Newswire / September 2, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital
NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL...
Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt
VANCOUVER, BC / ACCESS Newswire / September 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:XPHYF)(FSE:4XT) is...
Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth
Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the...
Contract Research Organization (CRO) Services Market worth $125.95 billion in 2030 with 8.3% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Sept. 1, 2025 /PRNewswire/ -- The global Contract Research Organization Services Market, valued at US$79.10 billion in...
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS...
Pharma Contract Manufacturing is the Quiet Reshoring Engine Investors Can’t Ignore
Black Book Flash Survey of VCs, PEs, Bankers, Analysts and Influencers Reveals Q4's Hottest Healthcare Investment NEW YORK CITY, NY...
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded...
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis...
Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
Illustrative image Laboratory, Boehringer Ingelheim This press release is not intended for UK and US media. HERNEXEOS® (zongertinib tablets) has been...
Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American...